UBS Downgrades Braskem to Sell, Lowers Price Target to $1.5
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsDowngradesPrice Target
UBS analyst Tasso Vasconcellos downgrades Braskem (NYSE:BAK) from Neutral to Sell and lowers the price target from $4 to $1.5.
UBS analyst Tasso Vasconcellos downgrades Braskem (NYSE:BAK) from Neutral to Sell and lowers the price target from $4 to $1.5.